Cargando…
Exacerbation of Atopic Dermatitis Associated with Ustekinumab Treatment in Crohn's Disease
Ustekinumab inhibits interleukins 12 and 23 and modulates the T helper cell-mediated immune response of Crohn's disease. However, ustekinumab may also exacerbate atopic disease by increasing the T helper 2 cell-mediated pathway. We present the first known case of exacerbation of atopic dermatit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617006/ https://www.ncbi.nlm.nih.gov/pubmed/36320969 http://dx.doi.org/10.7759/cureus.29718 |